Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
JACC Podcast - En podkast av American College of Cardiology
Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Subodh Verma MD, PhD explore a secondary analysis of the SELECT trial, a landmark study investigating the cardiovascular benefits of semaglutide in people with obesity or overweight without diabetes.
